Considering their effects during pregnancy, luteolin and kaempferol inhibited infection-induced inflammation in gestational tissues by reducing proinflammatory cytokines (IL-6 and IL-8) and prostaglandins (PGE2 and PGF2α) expression, indicating their potential therapeutic effect for preterm birth (Wall et al., 2013). This evidence concerns the gene IL6 and infection.